Drug intelligence / Profile preview

IAA-94

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal
01

Overview

IAA-94 is a small molecule chloride channel blocker that acts as a potent inhibitor of Chloride Intracellular Channel 1 (CLIC1). It is primarily utilized as a research tool to investigate the role of chloride channels in cellular signaling, particularly in the context of oxidative stress and vascular remodeling. In preclinical models of pulmonary hypertension (PH), IAA-94 has been shown to reduce right ventricular systolic pressure (RVSP), attenuate vascular remodeling, and restore mitochondrial function by disrupting the CLIC1/RALY signaling axis. This axis facilitates communication between endothelial cells and smooth muscle cells, promoting the proliferative phenotype characteristic of PH. By inhibiting CLIC1, IAA-94 effectively ameliorates disease features in hemolytic PH models, positioning CLIC1 as a potential therapeutic target.

Other names
R(+)-IAA-94Indanyloxyacetic acid 94R(+)-[(6,7-dichloro-2-cyclopentyl-2,3-dihydro-2-methyl-1-oxo-1H-inden-5-yl)oxy]acetic acid
02

Targets

CLIC1 (Chloride intracellular channel protein 1)CLIC (Chloride intracellular channel protein family)ClC (CLC chloride channel family)H1 (Vacuolar protein sorting 45 homolog)

Beyond the preview

Go deeper on IAA-94.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IAA-94.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call